<bill session="110" type="h" number="2223" updated="2009-01-08T21:30:11-05:00">
	<status><introduced date="1178596800" datetime="2007-05-08"/></status>

	<introduced date="1178596800" datetime="2007-05-08"/>
	<titles>
		<title type="official" as="introduced">To direct the Director of the Office of National Drug Control Policy, in consultation with the Attorney General and the Secretary of Health and Human Services, to conduct a study on prescription drug take-back programs, and for other purposes.</title>
	</titles>
	<sponsor id="400324"/>
	<cosponsors>
		<cosponsor id="412218" joined="2007-05-08"/>
		<cosponsor id="400260" joined="2007-05-22"/>
		<cosponsor id="400241" joined="2007-06-26"/>
		<cosponsor id="400057" joined="2008-02-12"/>
		<cosponsor id="400283" joined="2007-06-18"/>
	</cosponsors>
	<actions>
		<action date="1178596800" datetime="2007-05-08"><text>Referred to the House Committee on Energy and Commerce.</text></action>
		<action date="1178596800" datetime="2007-05-08"><text>Referred to the Subcommittee on Health.</text></action>
	</actions>
	<committees>

	</committees>
	<relatedbills>

	</relatedbills>
	<subjects>

	</subjects>
	<amendments>

	</amendments>
	<summary>
	5/8/2007--Introduced.<br/>Requires the Director of the Office of National Drug Control Policy to study and report to Congress on prescription drug disposal programs in which individuals return unused prescription drugs to pharmacies or other locations, focusing on certain issues including: (1) best practices of such programs; (2) affects of such programs on pharmacies; and (3) training and infrastructure needed to ensure the success of such programs. Requires the Administrator of the Environmental Protection Agency (EPA) to conduct a study identifying the environmental impacts of current prescription drug disposal programs and methods.<br/>
	</summary>
</bill>
